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A corrigendum on
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential
template for novel pharmacotherapeutic agents in neuropsychiatric disorders
by Butelman, E. R., and Kreek, M. J. (2015) Front. Pharmacol. 6:190. doi: 10.3389/fphar.2015.00190
Reason for Corrigendum:
In the original review, we placed an incorrect citation in the following sentence:
“Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting
MOPr agonist in primates (when given contingently; Whitfield et al., 2015).”
The correct sentence and citation are as follows:
“Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting
MOPr agonist in primates (when given contingently; Freeman et al., 2014).”
The authors apologize for the mistake. This error does not change the scientific conclusions of the
review.
REFERENCES
Freeman, K. B., Naylor, J. E., Prisinzano, T. E., and Woolverton, W. L. (2014). Assessment of the kappa opioid agonist,
salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology (Berl.) 231, 2751–2758. doi:
10.1007/s00213-014-3436-2
Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or
financial relationships that could be construed as a potential conflict of interest.
Copyright © 2015 Butelman and Kreek. This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these terms.
